Research News on Targeted Therapies
-
Experts Say No to Avastin for Breast Cancer
An FDA expert panel recommended that Avastin not be used to treat advanced breast cancer. But doctors may still recommend the medicine depending on a woman's unique situation.
-
Inflammatory HER2-Positive Breast Cancer Responds to Herceptin
Inflammatory breast cancers that are HER2-positive are more likely to respond to Herceptin plus chemotherapy than chemotherapy alone.
-
Breast Cancer Vaccine Shows Promise in Early Tests
An early trial in 18 women with advanced HER2-positive breast cancer showed that a new vaccine appears to be safe.
-
Herceptin Approved in Europe to Treat Breast Cancer
Herceptin plus hormonal therapy for advanced breast cancer is approved in Europe.
-
Herceptin-Avastin Combo Shows Promise
Herceptin combined with Avastin may have benefits for women with HER2-positive, advanced breast cancer.
-
FDA Approves Herceptin to Treat Early-Stage Disease
The FDA has approved Herceptin for treating early-stage, HER2-positive, node-positive breast cancer.
-
Herceptin Plus Arimidex Can Help Treat Advanced-Stage Breast Cancer
Advanced breast cancers that are hormone-receptor-positive are commonly treated with hormonal therapy medicines such as Arimidex (chemical name: anastrazole). Advanced HER2-positive breast cancers are ...
